Meet our Head of Operations, @DoornKarlijn, and learn how she and her team work with pharma companies around the world to help physicians access drugs through our #expandedaccess programs for patients with unmet medical need. Watch our full video here: https://t.co/JjBX8VpYXc

@DoornKarlijn PhD, our Director of Operations, was a guest on the METAPHASE Podcast. She talks about her career path — spanning her PhD years, teaching at University of Amsterdam, and her experience at myTomorrows. Listen to the full episode here: https://t.co/CLoq3jZXAA

@myTomorrows is hosting a free webinar, How to Leverage Real-World Data from Expanded Access Programs, on Sept. 9th. Please join us to discover the potential of Real-World Data from Expanded Access Programs. #expandedaccess, #RWD, #realworlddata, #pharma https://t.co/sUJ9YwlBsy

Check out our latest blog to learn about the importance of developing a good expanded access policy and the benefits for all stakeholders that may arise from implementing one. #expandedaccess #compassionateuse #pharma

✨ Recently, Michel van Harten, MD, COO, has been appointed as CEO of @myTomorrows, managing the overall operations from August onwards. Find out the exclusive conversation with Michel van Harten in @SiliconCanals https://t.co/K8Cz5twYIi

We're launching the beta version of our new HCP Portal to help physicians with finding and ​facilitating access to #clinicaltrials and #expandedaccess programs. Read more here.

We are thrilled to announce that myTomorrows is a finalist in The Europas — the premier awards for Europe’s hottest tech startups! @TheEuropas recognize and celebrate the innovation of Europe’s #tech #startups. #healthtech Please vote for us here

Welcoming to the #Pinksocks tribe, our patient navigators and MD’s, who help patients with unmet medical needs 24/7. @schoorperion, @FrederiekeGrev1 and Dearra — Thnx @nickisnpdx and @EMoriartyWade for the positive vibes!

We're looking for a Manager Medical Affairs, with a Medical degree and an interest in #Oncology/Hematology/#RareDisease, to join our team to help more patients and physicians access treatments in development. https://t.co/R3ivUTS0Fj #MedTwitter #medicalaffairs #clinicaltrials

Check out this interview with our COO, Michel Van Harten, MD, about how myTomorrows has a mission to enable every patient to have earlier and better access to all possible treatment options. #clinicaltrials #expandedaccess #PatientEngagement https://t.co/WFgUChKs0M

Great interview with our COO on @myTomorrows

Where do patients and physicians turn when they’ve exhausted all other treatment options? @mytomorrows offers some hope 💫 my conversation with COO Michel van Harten 👉🏻

Learn more about diffuse large B cell lymphoma (DLBCL) in our blog. #DLBCL is the most commonly occurring sub-type of non-Hodgkin #lymphoma. #lymsm https://t.co/AqmyySZOK2

Searching for Gaucher disease clinical trials? Try our new search tool for finding global clinical trials --> https://t.co/QJ7SSFUyjC - #Gaucher #GaucherDisease #Clinicaltrials #raredisease

6/6 – To learn more read our recent blog post “Key considerations for operationalizing Expanded Access Programs” - https://t.co/3Svlghtf4z - #expandedaccess #compassionateuse #clinicaltrials #RWD

Join us next week March 2nd, for our panel discussion "Leveraging Rare Disease Expanded Access Data for Regulators and Payers" - Free registration --> https://t.co/NjR45MbY3h - #RWD #ExpandedAccess #WODC #Rarediseaseday

Meet our Head of Medical Affairs, Dearra Prop, MD. She understands the challenges physicians and patients face when trying to access #clinicaltrials and #expandedaccess programs, and she is here to help alleviate those burdens. #MedTwitter https://t.co/hsTv2PtF10

Learn about strategic considerations for operationalizing your expanded access program. Here are 10 key factors that pharmaceutical companies should consider (and here’s how @myTomorrows can help). #expandedaccess #compassionateuse #pharma #realworlddata https://t.co/9yNz8iBQh4

Next week Feb 25th, 12PM ET/ 6PM CET - Our RWD lead @TBPolak will join an interesting panel discussion "Smarter Data Capture from Hybrid Trials and Treatment programs" organized by Ax-S Pharma - Register here--> https://t.co/EuGBvVK6tU #Clinicaltrials #ExpandedAccess #RWD

On #WorldCCADay, we are honored to share the story of Liesbeth van Boxtel and her search for #Cholangiocarcinoma clinical trials. Read about her journey here: https://t.co/fZ2ZkoY2AR - #curecca #bileductcancer